OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis

Clinical trial NCT04375878 · COMPLETED

Trial details

NCT number: NCT04375878
Sponsor: Entero Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Exocrine Pancreatic Insufficiency (EPI)Cystic Fibrosis (CF)

Start date: 2020-07-20
Primary completion: 2021-04-08
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.